This inventor holds 1 USPTO granted patent. Top assignee: Université Paul Cézanne Aix-Marseille III. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovator Frederico Andreoli: Pioneering Therapeutic Advancements
Introduction
Frederico Andreoli, a distinguished inventor based in Modena, Italy, has made a notable impact in the field of pharmaceuticals with his innovative approach to addressing complex medical conditions. With one patent to his name, Andreoli focuses on developing therapeutic agents that have the potential to improve the lives of patients suffering from Alzheimer's disease.
Latest Patents
Frederico Andreoli's patent centers around a novel process leading to new substituted 1H-benzo[d]imidazol-2(3H)-ones. This invention, designated as formula III and III', contributes valuable pharmaceutical compositions and outlines their use as therapeutic agents, particularly as inhibitors of BACE1, an essential target in the treatment of Alzheimer's disease. This groundbreaking approach could pave the way for advanced treatment options in neurodegenerative disorders.
Career Highlights
Currently, Frederico Andreoli contributes his expertise to Université Paul Cézanne Aix-Marseille III, where he collaborates with fellow researchers to propel innovations in pharmaceutical sciences. His singular focus on developing impactful solutions for critical health issues showcases his commitment to advancing medical knowledge and treatments.
Collaborations
Andreoli collaborates with esteemed colleagues such as Christian Roussel and Nicolas Daniel Pierre Vanthuyne. Through this synergistic partnership, they explore new research avenues and enhance their collective contributions to therapeutic innovation.
Conclusion
Frederico Andreoli stands out as an inventor dedicated to addressing significant health challenges through his innovative contributions in pharmacology. His work, particularly in developing new therapeutic agents for Alzheimer's disease, underscores the vital role of inventors in the continuous evolution of healthcare solutions. As he advances in his career, Andreoli is poised to make further contributions that may change the landscape of treatment for neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile